Fetal Dystocia (Fetal Malpresentation, Malposition, Fetal Anomaly / Monster Birth)

Fetal dystocia is a disorder of parturition in which the fetus fails to pass through the birth canal due to fetal factors, including malpresentation (abnormal orientation of the fetus relative to the maternal birth canal), malposition (abnormal posture of the fetal head, neck, or limbs), malposture (abnormal flexion or extension of fetal joints), or fetal anomalies (congenital malformations, fetal oversize, or fetal monsters). In veterinary theriogenology, fetal dystocia is a major cause of maternal and neonatal morbidity and mortality, requiring prompt diagnosis and intervention. The condition is classified based on the fetal component of the expulsive forces, the maternal pelvis, and the fetus itself. Fetal dystocia is distinguished from maternal dystocia, which arises from uterine inertia, pelvic canal abnormalities, or vaginal/vulvar strictures. The pathophysiological basis involves a mismatch between fetal dimensions and the maternal birth canal, or abnormal fetal orientation that prevents normal engagement and progression through the pelvic inlet, pelvic cavity, and vulvar opening. In bitches and queens, fetal dystocia is a common obstetric emergency, with an incidence ranging from 5% to 30% of all parturitions, depending on breed and management. The condition requires immediate veterinary attention to ensure fetal viability and maternal health, often necessitating obstetric manipulation, medical therapy, or cesarean section.

Fetal dystocia arises from a variety of fetal factors, including malpresentation, malposition, malposture, and fetal anomalies. Malpresentation refers to the orientation of the fetus relative to the birth canal, with the normal presentation being anterior (head-first) or posterior (breech) with the fetal spine oriented dorsally. Malpresentations include transverse presentation (fetus lying across the pelvic inlet), vertical presentation (fetus oriented with its long axis perpendicular to the maternal spine), and lateral presentation (fetal spine oriented ventrally or laterally). Malposition refers to the orientation of the fetal back relative to the maternal pelvis; normal position is dorsal (fetal spine against the maternal sacrum), but lateral or ventral positions can cause dystocia. Malposture involves abnormal flexion or extension of the fetal head, neck, or limbs, such as head deviation (lateral, ventral, or dorsal), shoulder flexion, elbow lock, hip flexion, or hock lock. Fetal anomalies include congenital malformations such as hydrocephalus, schistosomus reflexus, fetal ascites, fetal anasarca, conjoined twins, and fetal monsters (e.g., dicephalic, dipygus, or cyclopic fetuses). Fetal oversize (absolute fetal macrosomia) occurs when the fetus is too large for the maternal pelvis, often due to breed predisposition (e.g., brachycephalic breeds with large-headed fetuses) or small litter size leading to excessive fetal growth. Other etiologies include fetal death with emphysema or maceration, which can alter fetal shape and rigidity, and fetal–maternal disproportion due to maternal pelvic abnormalities. In some cases, iatrogenic factors such as improper obstetric manipulation can cause fetal malpresentation. The underlying mechanisms involve genetic factors, breed-specific conformational traits, and endocrine imbalances that affect fetal growth and development.

Fetal dystocia is a significant cause of obstetric emergencies in dogs and cats, with an overall incidence of approximately 5% to 30% in bitches and 5% to 20% in queens, depending on breed and population. Breed predisposition is well-documented: brachycephalic breeds (e.g., English Bulldog, French Bulldog, Boston Terrier, Pug) have a high incidence of fetal dystocia due to fetal macrosomia (large head and chest) and maternal pelvic abnormalities. Toy and miniature breeds (e.g., Chihuahua, Yorkshire Terrier, Pomeranian) are also prone to fetal dystocia due to small pelvic canals and fetal oversize. In cats, brachycephalic breeds (e.g., Persian, Himalayan) and breeds with large fetal heads (e.g., Maine Coon) show increased risk. Primiparous females are at higher risk than multiparous females, as are females with a history of previous dystocia. Fetal factors such as litter size influence risk: small litters (1-2 fetuses) can lead to fetal oversize, while large litters may cause fetal malpresentation due to crowding. Fetal anomalies are relatively rare but more common in certain breeds with genetic predispositions (e.g., chondrodysplastic breeds). The incidence of fetal dystocia is also influenced by maternal age, with older females having increased risk of uterine inertia and fetal oversize. In a study of 182 dystocia cases in bitches, fetal factors were identified as the cause in approximately 30% of cases, with malpresentation being the most common fetal cause. In queens, fetal dystocia is less common but still significant, with malpresentation and fetal oversize being the primary fetal causes. The condition is more prevalent in purebred animals due to selective breeding for conformational traits that predispose to dystocia.

The pathophysiology of fetal dystocia involves a complex interplay between fetal size, orientation, and maternal pelvic dimensions. Normal parturition requires the fetus to be in anterior or posterior presentation with the fetal spine oriented dorsally, and the head and forelimbs (in anterior presentation) or hindlimbs (in posterior presentation) extended to allow passage through the pelvic canal. Fetal dystocia occurs when these conditions are not met, leading to mechanical obstruction. In malpresentation, the fetus may be transverse or vertical, preventing engagement of the presenting part into the pelvic inlet. In malposition, the fetal spine is oriented laterally or ventrally, increasing the fetal diameter that must pass through the pelvis. In malposture, flexion or extension of the fetal head or limbs increases the fetal cross-sectional area, causing obstruction. Fetal anomalies such as hydrocephalus or fetal ascites increase fetal size or alter fetal shape, making passage impossible. Fetal oversize occurs when the fetus is too large relative to the maternal pelvis, often due to genetic factors or prolonged gestation. The mechanical obstruction leads to prolonged stage II labor, with strong uterine contractions and abdominal straining that fail to expel the fetus. This results in fetal stress, hypoxia, and death, as well as maternal exhaustion, uterine fatigue, and potentially uterine rupture. The fetal–maternal disproportion also compromises placental blood flow, leading to fetal hypoxia and acidosis. In cases of fetal death, the fetus may become emphysematous or macerated, further complicating delivery. The endocrinological changes during parturition, including the surge of prostaglandins and oxytocin, may be insufficient to overcome the mechanical obstruction, leading to secondary uterine inertia. The inflammatory response to tissue trauma and fetal death can cause systemic signs such as fever, toxemia, and septicemia, particularly if the birth canal is damaged or if there is uterine contamination.

Several intrinsic and extrinsic factors predispose to fetal dystocia. Intrinsic factors include breed-specific conformational traits, such as brachycephalic head shape and large fetal head circumference, which are common in English Bulldogs, French Bulldogs, and Boston Terriers. Toy and miniature breeds have small pelvic canals relative to fetal size, increasing the risk of fetal oversize. Primiparity is a significant risk factor, as the birth canal may be narrower and less distensible in first-time mothers. Maternal age, particularly older females, may have reduced pelvic elasticity and uterine tone. Genetic factors can cause fetal anomalies, such as chondrodysplasia, which is associated with fetal oversize and malpresentation. Hormonal imbalances, such as progesterone levels that remain elevated due to luteal persistence, can delay parturition and lead to fetal oversize. Extrinsic factors include improper breeding management, such as breeding at the wrong time, which can result in small litters and oversized fetuses. Nutritional factors, such as overfeeding during pregnancy, can lead to fetal macrosomia. Environmental stress, such as overcrowding or poor kennel conditions, may cause maternal anxiety and interfere with normal parturition. Iatrogenic factors, such as inappropriate use of oxytocin or improper obstetric manipulation, can cause fetal malpresentation or uterine rupture. Additionally, a history of previous dystocia or cesarean section may predispose to recurrence due to pelvic scarring or uterine adhesions.

Clinical signs of fetal dystocia include prolonged stage II labor, defined as more than 2-4 hours of active straining without delivery of a fetus, or more than 30-60 minutes of strong straining without progress. The female may exhibit signs of distress, such as restlessness, panting, vocalization, and frequent position changes. There may be a visible fetal sac or fetal parts at the vulva, but the fetus fails to be expelled. In cases of malpresentation, the fetal head or limbs may be visible but not progressing. The female may show signs of pain, such as abdominal tensing and guarding. Vaginal discharge may be present, ranging from clear to bloody or purulent, especially if there is fetal death or uterine infection. Systemic signs may include lethargy, depression, anorexia, vomiting, and fever, particularly if there is uterine rupture or sepsis. On abdominal palpation, the uterus may be tense and the fetus may be palpable in an abnormal orientation. Vaginal examination may reveal a fetus in an abnormal presentation, position, or posture, or a fetal anomaly. In cases of fetal death, there may be a foul-smelling vaginal discharge and signs of toxemia. The female may also show signs of secondary uterine inertia, with weak or absent contractions after prolonged straining. In severe cases, maternal collapse and shock may occur due to uterine rupture or hemorrhage.

Differential diagnoses for fetal dystocia include maternal dystocia due to uterine inertia (primary or secondary), which is characterized by weak or absent uterine contractions without fetal obstruction. Primary uterine inertia occurs when the uterus fails to contract effectively, often due to hypocalcemia, hypoglycemia, or uterine overdistension. Secondary uterine inertia results from uterine muscle fatigue after prolonged obstruction. Other differentials include maternal pelvic canal abnormalities, such as pelvic fractures, narrowing, or congenital malformations, which can be identified by digital examination or radiography. Vaginal or vulvar strictures, neoplasia, or edema can also obstruct delivery. Systemic diseases such as eclampsia (hypocalcemia) can cause muscle weakness and uterine inertia, but may be differentiated by serum calcium levels. Fetal death with emphysema or maceration can cause dystocia, but may be distinguished by ultrasonography or radiography. Other conditions that mimic dystocia include abortion or premature labor, which may present with vaginal discharge and straining, but can be differentiated by gestational age and fetal viability. Additionally, conditions such as uterine torsion or rupture can cause abdominal pain and straining, but are rare and may be diagnosed by imaging or exploratory surgery. A thorough physical examination, vaginal palpation, and imaging are essential to differentiate these conditions.

The diagnostic algorithm for fetal dystocia begins with a thorough history and physical examination. The clinician should assess the stage of labor, duration of straining, and any previous obstetric interventions. A complete physical examination should include assessment of maternal vital signs, hydration status, and abdominal palpation. Vaginal examination is crucial to determine fetal presentation, position, posture, and viability. The examiner should use sterile gloves and lubricant to palpate the pelvic canal and identify the fetal parts. If the fetus is not palpable, imaging is indicated. Abdominal radiography can confirm fetal number, size, and position, and can identify fetal anomalies such as hydrocephalus or fetal monsters. Ultrasonography is essential to assess fetal viability (heart rate, movement) and to evaluate the uterus for signs of rupture or infection. Serum biochemistry, including calcium, glucose, and progesterone levels, can rule out metabolic causes of uterine inertia. Vaginal cytology and bacterial culture may be performed if infection is suspected. The diagnostic algorithm should proceed stepwise: (1) confirm the diagnosis of dystocia based on prolonged stage II labor; (2) perform vaginal examination to identify fetal factors; (3) use imaging to assess fetal viability and maternal pelvic dimensions; (4) rule out maternal causes; (5) determine the need for medical or surgical intervention. In cases where fetal malpresentation is identified, the clinician must decide whether manual correction is feasible or if cesarean section is required.

Laboratory findings in fetal dystocia are variable and depend on the duration and severity of the condition. Hematology may reveal leukocytosis with a left shift, indicating inflammation or infection, particularly if there is uterine contamination or fetal death. Toxic neutrophils may be present in cases of sepsis. Biochemistry may show hypocalcemia (serum calcium < 8.0 mg/dL), which can contribute to uterine inertia, and hypoglycemia, which may cause maternal weakness. Elevated liver enzymes and azotemia may occur if there is tissue trauma or sepsis. Serum progesterone levels may be elevated (>2 ng/mL) if parturition is not imminent, but in true dystocia, progesterone should be <1 ng/mL. Vaginal cytology may show a mixture of superficial and intermediate cells, with the presence of neutrophils and bacteria if there is infection. Uterine or vaginal cultures may reveal bacterial growth, such as Escherichia coli, Streptococcus spp., or Staphylococcus spp., in cases of metritis. In cases of fetal death, there may be elevated inflammatory markers and evidence of fetal stress, such as increased cortisol levels. However, laboratory findings are often nonspecific, and the diagnosis is primarily based on clinical and imaging findings.

Imaging plays a critical role in the diagnosis and management of fetal dystocia. Abdominal radiography is useful to determine fetal number, size, and position. Fetal mineralization is visible on radiographs after day 42-45 of gestation, allowing assessment of fetal skeletal structures. Radiographic findings in fetal dystocia may include fetal oversize (fetal head or body diameter exceeding the maternal pelvic canal), fetal malpresentation (transverse or vertical orientation), fetal anomalies (e.g., hydrocephalus, schistosomus reflexus), or fetal death (gas accumulation within the fetus or uterus). Radiography can also assess the maternal pelvis for fractures or narrowing. Abdominal ultrasonography is essential to assess fetal viability by measuring fetal heart rate (normal > 220 bpm; bradycardia < 160 bpm indicates fetal distress) and fetal movement. Ultrasonography can also evaluate fetal presentation and posture, and detect fetal anomalies such as ascites or anasarca. The biparietal diameter (BPD) can be measured to estimate fetal size and predict dystocia. Uterine wall thickness and the presence of fetal fluids can be assessed. In cases of fetal death, ultrasonography may show absence of fetal heartbeats and movement, and the presence of gas echoes. CT and MRI are rarely used in veterinary obstetrics but may be indicated for complex cases, such as pelvic trauma or neoplasia. Vaginoscopy can be performed to visualize the vaginal canal and identify obstructions, but is less commonly used than digital palpation.

Cytological and histopathological findings are not typically the primary diagnostic tools for fetal dystocia, but they can provide valuable information in certain contexts. Vaginal cytology may be performed to assess the stage of the estrous cycle and to detect inflammation or infection. In a female with dystocia, vaginal cytology may show a mix of superficial and intermediate cells, with the presence of neutrophils and bacteria if there is vaginitis or metritis. Histopathology of the uterus or placenta may be obtained during cesarean section or ovariohysterectomy. Uterine histopathology may reveal endometritis, with infiltration of neutrophils and plasma cells, or evidence of uterine rupture, such as hemorrhage and necrosis. Placental histopathology may show signs of inflammation, infarction, or fetal membrane retention. In cases of fetal anomalies, histopathology of the fetus may be performed to identify congenital malformations. However, these findings are often secondary to the primary diagnosis of fetal dystocia and are used to guide treatment and prognosis.

The treatment of fetal dystocia depends on the severity of the condition, fetal viability, and the presence of maternal complications. Initial stabilization includes intravenous fluid therapy to correct dehydration and electrolyte imbalances, and calcium gluconate (10% solution, 0.5-1.5 mL/kg IV slowly to effect) if hypocalcemia is present. If the fetus is alive and the malpresentation is correctable, manual manipulation may be attempted. This involves gentle vaginal manipulation to reposition the fetus, using lubrication and obstetric techniques such as repulsion, rotation, and traction. However, manual correction is often unsuccessful in cases of fetal oversize or anomalies. Medical therapy may be used to stimulate uterine contractions if there is no obstruction, but oxytocin (2-5 IU IM or IV, repeated at 30-minute intervals) should be used with caution, as it can cause uterine rupture if there is obstruction. Prostaglandin F2alpha (dinoprost 0.1-0.25 mg/kg SC) may be used to enhance uterine contractions, but is less commonly used. If medical management fails or if there is fetal distress, cesarean section is indicated. Cesarean section is the definitive treatment for fetal dystocia and should be performed promptly to maximize fetal survival. The surgical approach may be midline or flank, and the uterus is incised to deliver the fetuses. Ovariohysterectomy may be performed if there is uterine necrosis, rupture, or infection. Postoperative care includes antibiotics (e.g., amoxicillin-clavulanate 12.5-25 mg/kg PO q12h), analgesics (e.g., carprofen 2-4 mg/kg PO q12h or meloxicam 0.1-0.2 mg/kg PO q24h), and supportive care. In cases of fetal death, the fetus must be removed to prevent maternal sepsis. If the fetus is too large or malformed, a fetotomy may be considered, but this is rarely performed in small animals due to the risk of maternal injury. In all cases, the goal is to deliver viable fetuses and preserve maternal health.

The prognosis for fetal dystocia depends on the underlying cause, the duration of dystocia, and the timeliness of intervention. If treated promptly, the prognosis for maternal survival is excellent, with a maternal mortality rate of less than 5%. Fetal survival is more variable, with reported rates of 60-90% for live fetuses if cesarean section is performed within 2-4 hours of the onset of stage II labor. Fetal survival decreases significantly with prolonged dystocia, with rates dropping to 20-30% after 6 hours. The prognosis is worse in cases of fetal death, fetal anomalies, or maternal complications such as uterine rupture or sepsis. Future fertility is generally preserved if the uterus is not severely damaged and if the female is not ovariohysterectomized. However, females with a history of fetal dystocia may have an increased risk of recurrence, particularly if the cause is breed-related or if there is a pelvic abnormality. Negative prognostic indicators include fetal bradycardia (<160 bpm), fetal death, maternal fever, and the presence of purulent vaginal discharge. With appropriate management, the overall prognosis is good, but early recognition and intervention are critical.

Post-treatment follow-up is essential to monitor maternal recovery and neonatal health. After cesarean section or manual delivery, the female should be monitored for signs of infection, hemorrhage, or uterine involution. Serial ultrasonography may be performed to assess uterine involution and to detect any retained fetal membranes or uterine infection. Serum progesterone levels should be monitored to ensure they decline to baseline (<1 ng/mL) within 24-48 hours after delivery. Vaginal discharge should be monitored for color, odor, and duration; a purulent or foul-smelling discharge may indicate metritis. The female should be evaluated for signs of eclampsia, particularly if she is nursing a large litter. Neonates should be monitored for viability, weight gain, and nursing behavior. A follow-up examination is recommended at 2-4 weeks postpartum to assess uterine involution and to discuss future breeding plans. If the female is to be bred again, a breeding audit should be performed, including assessment of pelvic conformation, fetal size, and previous dystocia history. In cases of recurrent dystocia, elective cesarean section may be recommended. The owner should be educated on the signs of dystocia and the importance of prompt veterinary care.

Clinical pearls: (1) Always assess fetal viability before attempting manual correction; if fetal heart rate is <160 bpm, immediate cesarean section is indicated. (2) Use ultrasonography to confirm fetal number and presentation; radiography may underestimate fetal count. (3) In brachycephalic breeds, anticipate fetal oversize and consider elective cesarean section. (4) Oxytocin should never be administered if there is evidence of obstruction, as it can cause uterine rupture. (5) Calcium gluconate should be given slowly IV while monitoring cardiac rhythm. (6) In cases of fetal death, remove the fetus promptly to prevent maternal sepsis. Pitfalls: (1) Delaying cesarean section in favor of prolonged medical management can lead to fetal and maternal death. (2) Attempting manual correction without adequate lubrication or sedation can cause vaginal trauma. (3) Failing to recognize secondary uterine inertia can lead to misdiagnosis of primary inertia. (4) Overlooking maternal hypocalcemia can result in ineffective uterine contractions. (5) Not performing a thorough vaginal examination can miss fetal malpresentation. (6) Using high doses of oxytocin (e.g., >5 IU) can cause tetanic contractions and fetal hypoxia.

Current drug protocols for fetal dystocia include: (1) Oxytocin (Pitocin) at 2-5 IU per dog or cat, administered IM or IV, repeated every 30 minutes for a maximum of 2-3 doses, only after confirming no obstruction. (2) Calcium gluconate 10% solution, 0.5-1.5 mL/kg IV slowly to effect, for hypocalcemia. (3) Prostaglandin F2alpha (dinoprost tromethamine) at 0.1-0.25 mg/kg SC, or cloprostenol at 1-2 mcg/kg SC, used to enhance uterine contractions, but with caution. (4) Aglepristone (Alizin) at 10 mg/kg SC, used to terminate pregnancy or induce abortion, but not typically used for dystocia. (5) Cabergoline (Galastop) at 5 mcg/kg PO q24h for 4-6 days, used to reduce prolactin and treat pseudopregnancy, but not for dystocia. (6) Antibiotics: amoxicillin-clavulanate (12.5-25 mg/kg PO q12h) or cefazolin (22 mg/kg IV q8h) for prophylaxis or treatment of infection. (7) Analgesics: carprofen (2-4 mg/kg PO q12h) or meloxicam (0.1-0.2 mg/kg PO q24h) for postoperative pain. (8) Fluid therapy: isotonic crystalloids (e.g., lactated Ringer's solution) at 10-20 mL/kg/h IV for shock. (9) In cases of uterine inertia, a combination of calcium gluconate and oxytocin may be used, but only after ruling out obstruction. (10) For fetal resuscitation, doxapram (1-2 mg/kg IV or sublingual) may be used in neonates. All dosages should be adjusted based on the patient's condition and response.

Evidence-based literature on fetal dystocia in dogs and cats is limited but provides important insights. A retrospective study of 182 dystocia cases in bitches found that fetal factors were the cause in 30% of cases, with malpresentation being the most common. The study reported a fetal survival rate of 92% when cesarean section was performed within 2 hours of the onset of stage II labor, dropping to 50% after 6 hours. Another study in queens reported a similar incidence of fetal dystocia, with fetal oversize being the most common cause. A prospective study comparing medical management (oxytocin and calcium) to surgical management (cesarean section) found that cesarean section resulted in higher fetal survival rates and lower maternal morbidity. The American College of Theriogenologists (ACT) and the European Society for Small Animal Reproduction (EVSSAR) have published consensus guidelines recommending early intervention in cases of fetal dystocia, with cesarean section indicated if medical management fails within 30-60 minutes. A meta-analysis of cesarean section outcomes in brachycephalic breeds reported a high incidence of fetal dystocia and recommended elective cesarean section in these breeds. The use of aglepristone for the management of fetal death has been described, but its role in dystocia is limited. Overall, the literature supports prompt surgical intervention for fetal dystocia to optimize outcomes.